Long-term outcomes of donation after cardiac death liver allografts from a single center

:  Organ shortage continues to be a major challenge in transplantation. Recent experience with controlled non‐heart‐beating or donation after cardiac death (DCD) are encouraging. However, long‐term outcomes of DCD liver allografts are limited. In this study, we present outcomes of 19 DCD liver allog...

Full description

Saved in:
Bibliographic Details
Published inClinical transplantation Vol. 23; no. 2; pp. 168 - 173
Main Authors Nguyen, Justin H., Bonatti, Hugo, Dickson, Rolland C., Hewitt, Winston R., Grewal, Hani P., Willingham, Darrin L., Harnois, Denise M., Schmitt, Timothy M., Machicao, Victor I., Ghabril, Marwan S., Keaveny, Andrew P., Aranda-Michel, Jaime, Satyanarayana, Raj, Rosser, Barry G., Hinder, Ronald A., Steers, Jeffery L., Hughes, Christopher B.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.03.2009
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary::  Organ shortage continues to be a major challenge in transplantation. Recent experience with controlled non‐heart‐beating or donation after cardiac death (DCD) are encouraging. However, long‐term outcomes of DCD liver allografts are limited. In this study, we present outcomes of 19 DCD liver allografts with follow‐up >4.5 years. During 1998–2001, 19 (4.1%) liver transplants (LT) with DCD allografts were performed at our center. Conventional heart‐beating donors included 234 standard criteria donors (SCD) and 214 extended criteria donors (ECD). We found that DCD allografts had equivalent rates of primary non‐function and biliary complications as compared with SCD and ECD. The overall one‐, two‐, and five‐yr DCD graft and patient survival was 73.7%, 68.4%, and 63.2%, and 89.5%, 89.5%, and 89.5%, respectively. DCD graft survival was similar to graft survival of SCD and ECD in non hepatitis C virus (HCV) recipients (p > 0.370). In contrast, DCD graft survival was significantly reduced in HCV recipients (p = 0.007). In conclusion, DCD liver allografts are durable and have acceptable long‐term outcomes. Further research is required to assess the impact of HCV on DCD allograft survival.
Bibliography:ark:/67375/WNG-X0P01H0L-N
ArticleID:CTR968
istex:19E243FBBDE0E2BA47116DC664F88508A21FD683
Dr. Hugo Bonatti is a visiting surgical fellow who contributed equally to the preparation of this article. Dr. Bonatti is sponsored by the Detiger fellowship.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0902-0063
1399-0012
DOI:10.1111/j.1399-0012.2009.00968.x